Literature DB >> 11079623

Virulent Treponema pallidum 47 kDa antigen regulates the expression of cell adhesion molecules and binding of T-lymphocytes to cultured human dermal microvascular endothelial cells.

K H Lee1, H J Choi, M G Lee, J B Lee.   

Abstract

Perivasculitis and endothelial cell abnormalities are prominent histopathologic features of syphilis. Various cutaneous lesions are the main clinical features of syphilis. We examined whether Treponema pallidum 47 kDa antigen regulates the expression of cell adhesion molecules on human dermal microvascular endothelial cells (HDMEC) and the regulation of T-lymphocytes binding to HDMEC. Using immunofluorescence flow cytometry and enzyme-linked immunosorbent assay (ELISA), we demonstrated that T. pallidum upregulated the expression of adhesion molecules, including intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1) and E-selectin. The 47 kDa antigen of T. pallidum also activated endothelium as measured by the upregulation of the expression of adhesion molecules on HDMEC, and it also promoted an increased adherence of T-lymphocytes to HDMEC. The expressions of ICAM-1 and VCAM-1 on HDMEC and the adherence of T-lymphocytes to HDMEC were inhibited by treatment with anti-TNF-alpha antibody or anti-IL-1alpha antibody. These results show that T. pallidum or T. pallidum-specific 47 kDa antigen are capable of stimulating HDMEC to increase the expression of ICAM-1, VCAM-1 and E-selectin and thereby, promote the adherence of T-lymphocytes. The whole process may play an important role in the immunopathogenesis of syphilis and it is likely that TNF-alpha and IL-1alpha are involved.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11079623     DOI: 10.3349/ymj.2000.41.5.623

Source DB:  PubMed          Journal:  Yonsei Med J        ISSN: 0513-5796            Impact factor:   2.759


  8 in total

Review 1.  Syphilis: using modern approaches to understand an old disease.

Authors:  Emily L Ho; Sheila A Lukehart
Journal:  J Clin Invest       Date:  2011-12-01       Impact factor: 14.808

Review 2.  Biological basis for syphilis.

Authors:  Rebecca E Lafond; Sheila A Lukehart
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

Review 3.  The immunopathobiology of syphilis: the manifestations and course of syphilis are determined by the level of delayed-type hypersensitivity.

Authors:  J Andrew Carlson; Ganary Dabiri; Bernard Cribier; Stewart Sell
Journal:  Am J Dermatopathol       Date:  2011-07       Impact factor: 1.533

4.  The multifunctional role of the pallilysin-associated Treponema pallidum protein, Tp0750, in promoting fibrinolysis and extracellular matrix component degradation.

Authors:  Simon Houston; Shannon Russell; Rebecca Hof; Alanna K Roberts; Paul Cullen; Kyle Irvine; Derek S Smith; Christoph H Borchers; Michelle L Tonkin; Martin J Boulanger; Caroline E Cameron
Journal:  Mol Microbiol       Date:  2014-01-07       Impact factor: 3.501

5.  Recombinant Treponema pallidum protein Tp0965 activates endothelial cells and increases the permeability of endothelial cell monolayer.

Authors:  Rui-Li Zhang; Jing-Ping Zhang; Qian-Qiu Wang
Journal:  PLoS One       Date:  2014-12-16       Impact factor: 3.240

Review 6.  Novel Treponema pallidum Recombinant Antigens for Syphilis Diagnostics: Current Status and Future Prospects.

Authors:  Aleksey Kubanov; Anastassia Runina; Dmitry Deryabin
Journal:  Biomed Res Int       Date:  2017-04-24       Impact factor: 3.411

7.  Influence of hepatitis B virus co-infection on virological and immunological response to antiretroviral treatment among HIV patients attending comprehensive care clinics in Makueni County, Kenya.

Authors:  Geoffrey Mutisya Maitha; Gideon Kikuvi; Peter Wanzala; Fredrick Kirui
Journal:  Pan Afr Med J       Date:  2021-02-01

Review 8.  Possible effects of Treponema pallidum infection on human vascular endothelial cells.

Authors:  Bibo Xie; Tie Zhao; Sisi Zhao; Jie Zhou; Feijun Zhao
Journal:  J Clin Lab Anal       Date:  2022-03-10       Impact factor: 2.352

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.